Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.5 USD | +2.04% | +6.38% | +48.51% |
03-04 | Passage Bio, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
03-04 | Passage Bio, Inc. Appoints Kathleen Borthwick as Chief Financial Officer | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+48.51% | 90.57M | |
+4.97% | 109B | |
+11.27% | 105B | |
-0.38% | 22.25B | |
-12.21% | 22.09B | |
-7.66% | 18.68B | |
-36.52% | 17.58B | |
-9.85% | 16.85B | |
+4.51% | 13.76B | |
+34.99% | 12.46B |
- Stock Market
- Equities
- PASG Stock
- News Passage Bio, Inc.
- Chardan Trims Price Target on Passage Bio to $9 From $11, Keeps Buy Rating